Nu Skin Enterprises Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Nu Skin Enterprises.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Personal Products earnings growth | 33.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive
Apr 23
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Apr 17Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?
Mar 25Improved Revenues Required Before Nu Skin Enterprises, Inc. (NYSE:NUS) Stock's 27% Jump Looks Justified
Mar 06Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be $0.06
Feb 17Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load
Feb 15Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth
Jan 09Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns
Dec 21Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?
Nov 12Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nov 12The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%
Oct 04Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business
Aug 31Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price
Aug 13Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
May 13Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal
Mar 28Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty
Mar 04We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings
Feb 22Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06
Feb 19Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically
Feb 18Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks
Jan 18Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39
Nov 17Nu Skin: Is It Just A Growth Problem?
Oct 17Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Oct 09When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?
Sep 27Nu Skin: Attractive Valuation Trumps Near-Term Risks
Sep 12Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39
Aug 05Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 31In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nu Skin Enterprises has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 1,732 | -147 | 70 | 112 | N/A |
| 9/30/2024 | 1,775 | -103 | 91 | 140 | N/A |
| 6/30/2024 | 1,844 | -148 | 107 | 160 | N/A |
| 3/31/2024 | 1,905 | -3 | 85 | 144 | N/A |
| 12/31/2023 | 1,969 | 9 | 60 | 119 | N/A |
| 9/30/2023 | 2,003 | 59 | 38 | 90 | N/A |
| 6/30/2023 | 2,042 | 70 | 2 | 67 | N/A |
| 3/31/2023 | 2,102 | 77 | 18 | 78 | N/A |
| 12/31/2022 | 2,226 | 105 | 49 | 108 | N/A |
| 9/30/2022 | 2,377 | 38 | 129 | 192 | N/A |
| 6/30/2022 | 2,480 | 113 | 142 | 194 | N/A |
| 3/31/2022 | 2,624 | 139 | 108 | 168 | N/A |
| 12/31/2021 | 2,696 | 147 | 73 | 142 | N/A |
| 9/30/2021 | 2,770 | 230 | 61 | 127 | N/A |
| 6/30/2021 | 2,833 | 237 | 143 | 215 | N/A |
| 3/31/2021 | 2,741 | 219 | 227 | 291 | N/A |
| 12/31/2020 | 2,582 | 191 | 315 | 379 | N/A |
| 9/30/2020 | 2,417 | 158 | 272 | 334 | N/A |
| 6/30/2020 | 2,304 | 146 | 204 | 270 | N/A |
| 3/31/2020 | 2,315 | 150 | 183 | 255 | N/A |
| 12/31/2019 | 2,420 | 174 | 112 | 178 | N/A |
| 9/30/2019 | 2,520 | 116 | 136 | 217 | N/A |
| 6/30/2019 | 2,606 | 125 | 154 | 225 | N/A |
| 3/31/2019 | 2,686 | 129 | 124 | 196 | N/A |
| 12/31/2018 | 2,679 | 122 | 132 | 203 | N/A |
| 9/30/2018 | 2,662 | 158 | N/A | 261 | N/A |
| 6/30/2018 | 2,550 | 146 | N/A | 270 | N/A |
| 3/31/2018 | 2,396 | 137 | N/A | 280 | N/A |
| 12/31/2017 | 2,279 | 129 | N/A | 303 | N/A |
| 9/30/2017 | 2,144 | 149 | N/A | 246 | N/A |
| 6/30/2017 | 2,185 | 165 | N/A | 223 | N/A |
| 3/31/2017 | 2,235 | 167 | N/A | 299 | N/A |
| 12/31/2016 | 2,208 | 143 | N/A | 275 | N/A |
| 9/30/2016 | 2,249 | 141 | N/A | 266 | N/A |
| 6/30/2016 | 2,216 | 100 | N/A | 298 | N/A |
| 3/31/2016 | 2,176 | 100 | N/A | 245 | N/A |
| 12/31/2015 | 2,247 | 133 | N/A | 322 | N/A |
| 9/30/2015 | 2,284 | 144 | N/A | 337 | N/A |
| 6/30/2015 | 2,352 | 196 | N/A | 288 | N/A |
| 3/31/2015 | 2,442 | 171 | N/A | 178 | N/A |
| 12/31/2014 | 2,569 | 189 | N/A | -56 | N/A |
| 9/30/2014 | 3,016 | 268 | N/A | -105 | N/A |
| 6/30/2014 | 3,285 | 311 | N/A | 156 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NUS's forecast earnings growth is above the savings rate (2.8%).
Earnings vs Market: Insufficient data to determine if NUS's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if NUS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NUS's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if NUS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NUS's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 21:21 |
| End of Day Share Price | 2025/05/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nu Skin Enterprises, Inc. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anand Vankawala | Avondale Partners |
| Olivia Tong Cheang | BofA Global Research |
| April Scee | BTIG |